Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Moderna
MRNA
|
$923M |
| 2 |
Amazon
AMZN
|
$813M |
| 3 |
Apple
AAPL
|
$809M |
| 4 |
Microsoft
MSFT
|
$775M |
| 5 |
Tesla
TSLA
|
$664M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
$258M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
$124M |
| 5 |
Oracle
ORCL
|
$124M |
Sector Composition
| 1 | Technology | 24.55% |
| 2 | Financials | 13.94% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Provident Financial
PROV
$102M
| $653K | ﹤0.01% |
38,253
+5,408
| +16% | +$92.3K |
|
3902
VYNE Therapeutics
VYNE
$7.62M
| $653K | ﹤0.01% |
26,136
+214
| +0.8% | +$5.35K |
|
3903
Climb Global Solutions
CLMB
$594M
| $652K | ﹤0.01% |
24,211
+1,892
| +8% | +$51K |
|
|
NMRD
3904
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
| $650K | ﹤0.01% |
108,215
+23,593
| +28% | +$142K |
|
|
PLM
3905
DELISTED
PolyMet Mining Corp.
PLM
| $649K | ﹤0.01% |
213,071
+217
| +0.1% | +$661 |
|
3906
Lightpath Technologies
LPTH
$243M
| $647K | ﹤0.01% |
303,772
+120,870
| +66% | +$257K |
|
|
ZSAN
3907
DELISTED
Zosano Pharma Corporation
ZSAN
| $647K | ﹤0.01% |
25,723
+376
| +1% | +$9.46K |
|
|
HMPT
3908
DELISTED
Home Point Capital, Inc Common Stock
HMPT
| $644K | ﹤0.01% |
156,400
-8,742
| -5% | -$36K |
|
3909
Pangaea Logistics
PANL
$349M
| $643K | ﹤0.01% |
127,488
+19,514
| +18% | +$98.4K |
|
|
KVSA
3910
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
| $643K | ﹤0.01% |
65,183
| – | – |
|
3911
Forum Energy Technologies
FET
$309M
| $642K | ﹤0.01% |
28,521
-5,358
| -16% | -$121K |
|
3912
Immatics
IMTX
$761M
| $642K | ﹤0.01% |
49,448
+3,155
| +7% | +$41K |
|
|
LHDX
3913
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $639K | ﹤0.01% |
84,087
-10,586
| -11% | -$80.4K |
|
3914
Koss Corp
KOSS
$58.2M
| $638K | ﹤0.01% |
39,032
+2,938
| +8% | +$48K |
|
3915
Lantern Pharma
LTRN
$46.5M
| $637K | ﹤0.01% |
57,043
+1,564
| +3% | +$17.5K |
|
3916
Core Molding Technologies
CMT
$169M
| $635K | ﹤0.01% |
55,200
+5,568
| +11% | +$64.1K |
|
3917
AbCellera Biologics
ABCL
$1.26B
| $634K | ﹤0.01% |
31,664
-167,074
| -84% | -$3.35M |
|
|
LOGC
3918
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $634K | ﹤0.01% |
138,465
+6,344
| +5% | +$29K |
|
3919
Fuel Tech
FTEK
$89.2M
| $633K | ﹤0.01% |
363,880
+7,782
| +2% | +$13.5K |
|
3920
Comstock Holding Companies
CHCI
$187M
| $632K | ﹤0.01% |
132,209
+5,457
| +4% | +$26.1K |
|
3921
Consumer Portfolio Services
CPSS
$172M
| $630K | ﹤0.01% |
107,764
-1,075
| -1% | -$6.29K |
|
3922
LENSAR
LNSR
$145M
| $627K | ﹤0.01% |
79,741
+3,483
| +5% | +$27.4K |
|
3923
Ponce Financial Group
PDLB
$339M
| $626K | ﹤0.01% |
60,191
+4,448
| +8% | +$46.3K |
|
3924
P3 Health Partners
PIII
$28.7M
| $622K | ﹤0.01% |
1,263
| – | – |
|
3925
US Global Investors
GROW
$31.8M
| $621K | ﹤0.01% |
109,161
+1,724
| +2% | +$9.81K |
|